(Q43260317)

17 November 2017

Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. (English)

1 reference

17 November 2017

1 reference

1 reference

2

Mark Pimentel

1 reference

17 November 2017

David Law

1

1 reference

17 November 2017

16 October 2009

1 reference

Digestive Diseases and Sciences

17 November 2017

1 reference

17 November 2017

55

1 reference

17 November 2017

8

1 reference

17 November 2017

2302-2308

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-009-1010-2

17 November 2017

0 references

cites work

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1010-2

Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1010-2

Studying the overlap between IBS and GERD: a systematic review of the literature

21 January 2018

1 reference

12 December 2020

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

1 reference

12 December 2020

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

1 reference

12 December 2020

Somatic comorbidities of irritable bowel syndrome: a systematic analysis

1 reference

12 December 2020

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

1 reference

12 December 2020

Duodenal bacterial overgrowth during treatment in outpatients with omeprazole

1 reference

12 December 2020

Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

1 reference

12 December 2020

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

1 reference

12 December 2020

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

1 reference

12 December 2020

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea

1 reference

12 December 2020

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

1 reference

12 December 2020

Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life.

1 reference

12 December 2020

Prevalence of irritable bowel syndrome: a community survey

1 reference

12 December 2020

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

1 reference

12 December 2020

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

1 reference

12 December 2020

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

1 reference

12 December 2020

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

1 reference

12 December 2020

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?

1 reference

12 December 2020

Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly

1 reference

12 December 2020

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

1 reference

12 December 2020

Antibacterial activity of the pancreatic fluid.

1 reference

12 December 2020

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

1 reference

12 December 2020

Review article: proton pump inhibitors and bacterial overgrowth

1 reference

12 December 2020

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Overlap of gastrointestinal symptom complexes in a US community

1 reference

12 December 2020

10.1007/S10620-009-1010-2

Identifiers

DOI

1 reference

17 November 2017

1 reference

PubMed ID

19834807